If your hospital network is under a wound care management company contract right now, the arrangement probably made sense when it started.
Your administration did not have the internal capacity to run a specialized wound care program. The management company offered clinical expertise, operational structure, and billing support your team did not have time to build. That logic is sound. The problem is what happens next.
Management company contracts are designed to be renewed, not evaluated. By year three or four, most health systems are paying fees that have grown faster than their program, operating with less visibility than they expected, and working around physician frustration that nobody warned them about.
This article looks at what wound care management companies actually deliver, what they cost in ways the contract does not itemize, and what the alternative looks like for hospital networks that want to run advanced wound care centers without giving up control to do it.
The pitch from every major wound care management company is broadly the same. They bring clinical expertise, an established operational model, billing infrastructure, and a technology platform. They promise to take the complexity of running a wound center program off your plate. For a hospital that has never run a wound care program, that pitch addresses a real need.
The problem is that the model is built around dependency, not development. A management company's business model requires that the hospital continue needing them.
Clinical protocols are proprietary to the management company, making it difficult to transition away without disruption. Operational data is held inside the management company's platform, giving the hospital limited independent access to its own program performance. Supply contracts are managed by the management company, with margin built in that the hospital rarely sees itemized. Fee structures increase annually regardless of whether program performance improves.
None of this is hidden. It is just rarely examined until the hospital is already three or four years into a contract and the cost-benefit calculation has quietly shifted against them.
The costs that management company arrangements carry are not all financial. Some of the most significant ones do not appear on any invoice.
This is the most significant and least discussed cost. When a management company operates your wound care centers, clinical protocols and treatment approaches are standardized across the management company's entire client portfolio. Your physicians work within a framework designed for a different hospital's patient population and operational context.
When your clinical team identifies a better approach for your patients, the management company's response is often to defer to their established protocol rather than adapt to your program's needs. The result is physician disengagement. Experienced wound care physicians who feel they have no input into clinical standards pull back. Referrals slow. Volume plateaus. The management company's response is rarely to change the protocol.
Most management company arrangements put operational data inside the management company's reporting platform. That means the health system sees what the management company chooses to surface, formatted the way the management company prefers to present it, on a schedule the management company sets.
Health system executives routinely describe the same experience: they know the management company is generating reports, but they cannot independently query their wound center data. Volume by site. Denial rate by clinician. Documentation completion by shift. These should be questions a health system can answer about its own programs without making a phone call to a vendor. Without independent access to program data, health system leadership cannot identify underperforming sites before problems compound, cannot verify that billing accurately reflects clinical work performed, and cannot benchmark performance against the network average.
Wound care management companies negotiate supply contracts on behalf of their entire client portfolio. That sounds like a benefit. In practice, the management company captures the volume discount and passes through a price that includes their margin. Your hospital is not getting network-scale pricing. You are getting the management company's pricing, which is designed to be competitive enough to retain you while maintaining the margin that makes the supply relationship profitable for them.
When health systems consolidate their own purchasing at the network level rather than through a management company intermediary, the savings are typically significant. WCA network clients average a 68% reduction in purchase service expense after consolidation.
Management company contracts are typically multi-year arrangements with penalties for early termination. If a program is underperforming, the process for addressing it runs through the management company's account management structure, not through a direct conversation between your clinical leadership and an operations team that is accountable to your outcomes.
This delay is expensive. A documentation problem identified in January that reaches a resolution through the management company's correction process in April has produced three months of incorrect claims. A compliance gap that the management company's quarterly review catches in month four has run for four months across every affected site.
The support model is the structural alternative to wound care management company arrangements. It is designed around a different core principle: the hospital retains ownership and control of its wound care program, and the support partner provides the operational expertise and infrastructure the hospital needs to run it well.
Your physicians stay in place. Clinical decisions remain with your clinical team. Protocols are developed collaboratively, not imposed from a management company's standard playbook. Your data belongs to your hospital. Performance metrics, volume data, billing reports, and compliance records are accessible to your leadership team independently and in real time.
Supply agreements are negotiated at network scale for your benefit. The savings flow to your hospital, not to a management company's supply margin. Operational support is accountable to your outcomes. If a site underperforms, the correction happens immediately through the operations team, not through a quarterly account review process.
USC Verdugo Hills Hospital transitioned from a program with low volume and low revenue to a 62% volume increase and 100.5% revenue increase after WCA took over operations under this model. The CNO described the outcome directly: the partnership allows the hospital to deliver high-quality care while ensuring the financial well-being of the institution.
Not every hospital network should transition away from a management company arrangement. Some programs are early-stage and benefit from the structure a management company provides in the first two or three years. But four signals consistently indicate that the arrangement has stopped delivering value.
If your management fee has increased year over year while patient volume and revenue have stayed flat, the gap will not close by renegotiating the rate.
If answering basic operational questions requires a call to the management company, you do not have the visibility your program needs.
Physician disengagement in wound care is a leading indicator of volume decline. It rarely self-corrects inside a management company arrangement.
In the current CMS enforcement environment, quarterly compliance reviews are not sufficient. Documentation gaps that accumulate over a quarter represent real audit exposure.
The most common reason health systems stay in management company arrangements longer than is financially sensible is the assumption that transition is disruptive. That assumption is worth examining directly.
WCA has transitioned programs from multiple national wound care management companies. The process is designed to maintain care continuity throughout. WCA operates in parallel with the existing arrangement during the handoff period. There is no gap in patient care or clinical operations. The question is not whether transition is possible. The question is what it costs your network to delay it.
WCA offers a network assessment that compares your current management company arrangement against the support model on cost, control, and compliance. Start at thewca.com/contact
Yes. WCA has managed transitions from multiple national wound care management company arrangements. The transition is structured to maintain care continuity throughout, with WCA operating in parallel during the handoff period so there is no gap in patient care. The timeline depends on your current contract terms and network size.
No. WCA's support model keeps your existing physicians in their current roles. Clinical education and training through Luvo is designed to supplement clinical expertise your team already has, covering wound care advances, compliance updates, and documentation best practices. It is not a retraining program for new systems.
WCA's model eliminates the management company overhead layer, which includes corporate margin, regional management salaries, account retention costs, and supply contract markups. Most hospital networks that transition from a management company to WCA's support model see a meaningful reduction in total wound care operational costs in the first year. WCA can run a side-by-side cost comparison as part of the network assessment.
WCA reviews contract terms as part of the transition planning process and can help structure the timing to minimize or eliminate penalty exposure. Many contracts have performance-related exit provisions that have never been evaluated. In some cases, the management company's own performance record provides grounds for transition without penalty.
